NVO
Price:
$87.44
Market Cap:
$2.61T
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for deliveri...[Read more]
Industry
Biotechnology
IPO Date
1981-04-30
Stock Exchange
NYSE
Ticker
NVO
According to Novo Nordisk A/S’s latest financial reports and current stock price. The company's current Current Ratio is 0.94. This represents a change of 9.96% compared to the average of 0.85 of the last 4 quarters.
The mean historical Current Ratio of Novo Nordisk A/S over the last ten years is 1.09. The current 0.94 Current Ratio has changed 8.47% with respect to the historical average. Over the past ten years (40 quarters), NVO's Current Ratio was at its highest in in the December 2014 quarter at 1.37. The Current Ratio was at its lowest in in the March 2024 quarter at 0.70.
Average
1.09
Median
1.07
Minimum
0.82
Maximum
1.37
Discovering the peaks and valleys of Novo Nordisk A/S Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.01%
Maximum Annual Current Ratio = 1.37
Minimum Annual Increase = -20.85%
Minimum Annual Current Ratio = 0.82
Year | Current Ratio | Change |
---|---|---|
2023 | 0.82 | -7.99% |
2022 | 0.89 | 4.01% |
2021 | 0.86 | -8.15% |
2020 | 0.94 | -11.56% |
2019 | 1.06 | -2.90% |
2018 | 1.09 | -14.59% |
2017 | 1.28 | 1.34% |
2016 | 1.26 | -6.61% |
2015 | 1.35 | -1.82% |
2014 | 1.37 | -20.85% |
The current Current Ratio of Novo Nordisk A/S (NVO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
0.86
5-year avg
0.91
10-year avg
1.09
Novo Nordisk A/S’s Current Ratio is less than Regeneron Pharmaceuticals, Inc. (5.28), less than CRISPR Therapeutics AG (21.64), less than Sarepta Therapeutics, Inc. (3.84), less than Intellia Therapeutics, Inc. (6.73), less than Moderna, Inc. (4.39), less than CureVac N.V. (6.20), greater than Novavax, Inc. (0.93), less than CohBar, Inc. (15.69), less than Reata Pharmaceuticals, Inc. (6.75), less than BioNTech SE (7.33), less than Ginkgo Bioworks Holdings, Inc. (5.79), less than Vertex Pharmaceuticals Incorporated (2.47), less than BioMarin Pharmaceutical Inc. (4.27), less than Seagen Inc. (2.67), less than Alnylam Pharmaceuticals, Inc. (2.75), less than Madrigal Pharmaceuticals, Inc. (5.98), less than Intercept Pharmaceuticals, Inc. (4.22), less than TG Therapeutics, Inc. (4.59), less than Terns Pharmaceuticals, Inc. (32.99), less than Hepion Pharmaceuticals, Inc. (1.30),
Company | Current Ratio | Market cap |
---|---|---|
5.28 | $77.21B | |
21.64 | $3.49B | |
3.84 | $11.64B | |
6.73 | $1.23B | |
4.39 | $15.50B | |
6.20 | $670.67M | |
0.93 | $1.36B | |
15.69 | $1.77M | |
6.75 | $6.57B | |
7.33 | $27.36B | |
5.79 | $535.70M | |
2.47 | $105.12B | |
4.27 | $12.70B | |
2.67 | $43.15B | |
2.75 | $31.37B | |
5.98 | $6.80B | |
4.22 | $794.69M | |
4.59 | $5.01B | |
32.99 | $492.65M | |
1.30 | $3.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novo Nordisk A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novo Nordisk A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Novo Nordisk A/S's Current Ratio?
How is the Current Ratio calculated for Novo Nordisk A/S (NVO)?
What is the highest Current Ratio for Novo Nordisk A/S (NVO)?
What is the 3-year average Current Ratio for Novo Nordisk A/S (NVO)?
What is the 5-year average Current Ratio for Novo Nordisk A/S (NVO)?
How does the current Current Ratio for Novo Nordisk A/S (NVO) compare to its historical average?